HIV, Placental Lesions, and Adverse Perinatal Outcomes.
Where this comes from
- Record sourced from PubMed, PMID 34882204.
- Also identified by DOI 10.1093/infdis/jiab494.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Africa has the highest number of pregnant women with human immunodeficiency virus (HIV). In some studies, HIV has been associated with adverse perinatal outcomes. However, the pathophysiological mechanism leading to adverse fetal outcomes is not known. Maternal vascular malformation, chorioamnionitis, and decreased placental weight have been described as placental features associated with HIV in some studies. The use of antiretroviral therapy has reduced perinatal transmission of HIV and adverse fetal outcomes. However, placental mechanisms associated with HIV and the fetal immune response to maternal HIV infection are poorly understood. Additional research is required to understand whether altered maternal immunity in women living with HIV can trigger fetal responses leading to stillbirth or preterm birth.
Medical subject headings
- Fetal Growth Retardation
- HIV Infections
- Obstetric Labor, Premature
- Placenta
- Pregnancy Complications, Infectious
- Premature Birth
- Stillbirth